Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Exploring Undiscovered Gems in Europe This March 2025

In This Article:

As the pan-European STOXX Europe 600 Index ended a two-week losing streak with modest gains, driven by hopes of increased government spending, investors remain cautious amid ongoing trade tensions and mixed signals from central banks. In this landscape of uncertainty, identifying promising stocks often involves looking for companies that demonstrate resilience and potential for growth despite broader market challenges.

Top 10 Undiscovered Gems With Strong Fundamentals In Europe

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

FRoSTA

6.15%

4.62%

14.67%

★★★★★★

Linc

NA

19.35%

23.17%

★★★★★★

Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative

26.90%

4.14%

7.22%

★★★★★★

Flügger group

20.98%

3.24%

-29.82%

★★★★★☆

Dekpol

73.04%

15.36%

16.35%

★★★★★☆

Infinity Capital Investments

NA

9.92%

22.16%

★★★★★☆

ABG Sundal Collier Holding

0.61%

-1.57%

-8.96%

★★★★☆☆

Prim

10.72%

10.36%

0.14%

★★★★☆☆

Practic

NA

3.63%

6.85%

★★★★☆☆

Grenobloise d'Electronique et d'Automatismes Société Anonyme

0.01%

5.17%

-13.11%

★★★★☆☆

Click here to see the full list of 350 stocks from our European Undiscovered Gems With Strong Fundamentals screener.

Here's a peek at a few of the choices from the screener.

SpareBank 1 Nord-Norge

Simply Wall St Value Rating: ★★★★☆☆

Overview: SpareBank 1 Nord-Norge operates as a financial services provider in Northern Norway, with a market capitalization of NOK14.26 billion.

Operations: SpareBank 1 Nord-Norge generates revenue primarily from its Retail Market segment, contributing NOK2.51 billion, and Corporate Banking, adding NOK1.71 billion. The bank also earns from Sparebank 1 Finans Nord-Norge and Eiendoms-Megler 1 Nord-Norge with revenues of NOK344 million and NOK227 million respectively.

SpareBank 1 Nord-Norge, a noteworthy player in the European market, showcases robust financial health with total assets of NOK135.7 billion and equity of NOK19.3 billion. The bank's earnings surged by 43% over the past year, outpacing the industry average of 18%. Despite trading at 39% below its estimated fair value, it faces challenges with a high level of bad loans at 2.5% and an insufficient allowance for these loans. Recent announcements highlight a proposed dividend increase to NOK8.75 per share and significant net income growth to NOK3.63 billion from NOK2.52 billion last year.

OB:NONG Debt to Equity as at Mar 2025
OB:NONG Debt to Equity as at Mar 2025

Pexip Holding

Simply Wall St Value Rating: ★★★★★★